Advertisement
Screener

AMARIN CORP PLC\UK (AMRN) Increase (Decrease) in Accounts Payable and Other Operating Liabilities

2.8 / 5 stars · 68/120 Roast Me

AMARIN CORP PLC\UK Increase (Decrease) in Accounts Payable and Other Operating Liabilities

AMARIN CORP PLC\UK (AMRN) reported Increase (Decrease) in Accounts Payable and Other Operating Liabilities of -$30.26 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities · last filed 2026-07-29

  • AMARIN CORP PLC\UK increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2026-06-30 was -$15.45M, a 165.63% decline year-over-year.
  • AMARIN CORP PLC\UK increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2026-03-31 was -$14.81M.
  • AMARIN CORP PLC\UK increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2025-12-31 was $12.23M.
  • AMARIN CORP PLC\UK increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2025-09-30 was -$3.71M.
  • AMARIN CORP PLC\UK increase (decrease) in accounts payable and other operating liabilities for fiscal 2025 was $14.51M.
  • AMARIN CORP PLC\UK increase (decrease) in accounts payable and other operating liabilities for fiscal 2024 was -$76.99M.
  • AMARIN CORP PLC\UK increase (decrease) in accounts payable and other operating liabilities for fiscal 2023 was -$164.00K.
  • AMARIN CORP PLC\UK increase (decrease) in accounts payable and other operating liabilities for fiscal 2022 was -$102.73M, a 299.41% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 3 monthIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 3 month as first filedIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 6 monthIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 9 monthIncrease (Decrease) in Accounts Payable and Other Operating Liabilities 12 month
2026-06-30-$15.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
-$30.26M
10-Q · filed 2026-07-29
-$18.04M
derived: sum of 3 quarters · filed 2026-07-29
-$21.75M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31-$14.81M
10-Q · filed 2026-04-29
-$2.59M
derived: sum of 2 quarters · filed 2026-04-29
-$6.30M
derived: sum of 3 quarters · filed 2026-04-29
$17.24M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$12.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
$8.51M
derived: sum of 2 quarters · filed 2026-03-02
$32.05M
derived: sum of 3 quarters · filed 2026-07-29
$14.51M
10-K · filed 2026-03-02
2025-09-30-$3.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
$19.82M
derived: sum of 2 quarters · filed 2026-07-29
$2.28M
10-Q · filed 2025-10-29
-$19.32M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30$23.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
$6.00M
10-Q · filed 2026-07-29
-$15.61M
derived: sum of 3 quarters · filed 2026-07-29
-$44.60M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31-$17.54M
10-Q · filed 2026-04-29
-$39.15M
derived: sum of 2 quarters · filed 2026-04-29
-$68.13M
derived: sum of 3 quarters · filed 2026-04-29
-$59.63M
derived: sum of 4 quarters · filed 2026-04-29
2024-12-31-$21.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
-$50.59M
derived: sum of 2 quarters · filed 2026-03-02
-$42.09M
derived: sum of 3 quarters · filed 2026-03-02
-$76.99M
10-K · filed 2026-03-02
2024-09-30-$28.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
-$20.49M
derived: sum of 2 quarters · filed 2025-10-29
-$55.38M
10-Q · filed 2025-10-29
-$62.93M
derived: sum of 4 quarters · filed 2026-03-02
2024-06-30$8.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30
-$26.39M
10-Q · filed 2025-07-30
-$33.94M
derived: sum of 3 quarters · filed 2026-03-02
-$38.19M
derived: sum of 4 quarters · filed 2026-03-02
2024-03-31-$34.90M
10-Q · filed 2025-05-07
-$42.45M
derived: sum of 2 quarters · filed 2026-03-02
-$46.69M
derived: sum of 3 quarters · filed 2026-03-02
-$19.82M
derived: sum of 4 quarters · filed 2026-03-02
2023-12-31-$7.55M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
-$11.79M
derived: sum of 2 quarters · filed 2026-03-02
$15.07M
derived: sum of 3 quarters · filed 2026-03-02
-$164.00K
10-K · filed 2026-03-02
2023-09-30-$4.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30
$22.62M
derived: sum of 2 quarters · filed 2024-10-30
$7.39M
10-Q · filed 2024-10-30
-$20.67M
derived: sum of 4 quarters · filed 2025-03-12
2023-06-30$26.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31
$11.63M
10-Q · filed 2024-07-31
-$16.43M
derived: sum of 3 quarters · filed 2025-03-12
-$82.44M
derived: sum of 4 quarters · filed 2025-03-12
2023-03-31-$15.24M
10-Q · filed 2024-05-01
-$43.29M
derived: sum of 2 quarters · filed 2025-03-12
-$109.31M
derived: sum of 3 quarters · filed 2025-03-12
-$48.31M
derived: sum of 4 quarters · filed 2025-03-12
2022-12-31-$28.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12
-$94.07M
derived: sum of 2 quarters · filed 2025-03-12
-$33.07M
derived: sum of 3 quarters · filed 2025-03-12
-$102.73M
10-K · filed 2025-03-12
2022-09-30-$66.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
-$5.01M
derived: sum of 2 quarters · filed 2023-11-01
-$74.67M
10-Q · filed 2023-11-01
-$68.74M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$61.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
-$8.66M
10-Q · filed 2023-08-02
-$2.72M
derived: sum of 3 quarters · filed 2024-02-29
-$8.42M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$69.66M
10-Q · filed 2023-05-03
-$63.72M
derived: sum of 2 quarters · filed 2024-02-29
-$69.42M
derived: sum of 3 quarters · filed 2024-02-29
-$24.62M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$5.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$237.00K
derived: sum of 2 quarters · filed 2024-02-29
$45.04M
derived: sum of 3 quarters · filed 2024-02-29
$51.52M
10-K · filed 2024-02-29
2021-09-30-$5.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27
$39.10M
derived: sum of 2 quarters · filed 2022-10-27
$45.58M
10-Q · filed 2022-10-27
$39.08M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30$44.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
$51.28M
10-Q · filed 2022-08-03
$44.78M
derived: sum of 3 quarters · filed 2023-03-01
$100.49M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31$6.48M
10-Q · filed 2022-05-04
-$20.00K
derived: sum of 2 quarters · filed 2023-03-01
$55.69M
derived: sum of 3 quarters · filed 2023-03-01
$41.94M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31-$6.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$49.21M
derived: sum of 2 quarters · filed 2023-03-01
$35.46M
derived: sum of 3 quarters · filed 2023-03-01
$114.74M
10-K · filed 2023-03-01
2020-09-30$55.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03
$41.95M
derived: sum of 2 quarters · filed 2021-11-03
$121.24M
10-Q · filed 2021-11-03
$132.19M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30-$13.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$65.53M
10-Q · filed 2021-08-05
$76.48M
derived: sum of 3 quarters · filed 2022-03-01
$116.68M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$79.28M
10-Q · filed 2021-04-29
$90.24M
derived: sum of 2 quarters · filed 2022-03-01
$130.43M
derived: sum of 3 quarters · filed 2022-03-01
$147.44M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$10.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$51.15M
derived: sum of 2 quarters · filed 2022-03-01
$68.15M
derived: sum of 3 quarters · filed 2022-03-01
$65.91M
10-K · filed 2022-03-01
2019-09-30$40.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$57.20M
derived: sum of 2 quarters · filed 2020-11-05
$54.96M
10-Q · filed 2020-11-05
$56.56M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$17.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
$14.77M
10-Q · filed 2020-08-04
$16.36M
derived: sum of 3 quarters · filed 2021-02-25
$28.22M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$2.24M
10-Q · filed 2020-04-30
-$641.00K
derived: sum of 2 quarters · filed 2021-02-25
$11.22M
derived: sum of 3 quarters · filed 2021-02-25
$26.24M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$1.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$13.46M
derived: sum of 2 quarters · filed 2021-02-25
$28.48M
derived: sum of 3 quarters · filed 2021-02-25
$37.60M
10-K · filed 2021-02-25
2018-09-30$11.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$26.88M
derived: sum of 2 quarters · filed 2019-11-05
$36.01M
10-Q · filed 2019-11-05
$52.60M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$15.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
$24.15M
10-Q · filed 2019-07-31
$40.74M
derived: sum of 3 quarters · filed 2020-02-25
$42.70M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$9.12M
10-Q · filed 2019-05-01
$25.72M
derived: sum of 2 quarters · filed 2020-02-25
$27.68M
derived: sum of 3 quarters · filed 2020-02-25
$33.81M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$16.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$18.56M
derived: sum of 2 quarters · filed 2020-02-25
$24.69M
derived: sum of 3 quarters · filed 2020-02-25
$40.27M
10-K · filed 2020-02-25
2017-09-30$1.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$8.09M
derived: sum of 2 quarters · filed 2018-11-01
$23.67M
10-Q · filed 2018-11-01
$22.23M
derived: sum of 4 quarters · filed 2019-02-27
2017-06-30$6.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
$21.71M
10-Q · filed 2018-08-01
$20.27M
derived: sum of 3 quarters · filed 2019-02-27
$19.64M
derived: sum of 4 quarters · filed 2019-02-27
2017-03-31$15.58M
10-Q · filed 2018-05-02
$14.14M
derived: sum of 2 quarters · filed 2019-02-27
$13.51M
derived: sum of 3 quarters · filed 2019-02-27
$19.75M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31-$1.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
-$2.07M
derived: sum of 2 quarters · filed 2019-02-27
$4.17M
derived: sum of 3 quarters · filed 2019-02-27
$8.71M
10-K · filed 2019-02-27
2016-09-30-$624.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01
$5.62M
derived: sum of 2 quarters · filed 2017-11-01
$10.15M
10-Q · filed 2017-11-01
$5.74M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$6.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$10.77M
10-Q · filed 2017-08-02
$6.36M
derived: sum of 3 quarters · filed 2018-02-27
$14.29M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$4.53M
10-Q · filed 2017-05-03
$118.00K
derived: sum of 2 quarters · filed 2018-02-27
$8.04M
derived: sum of 3 quarters · filed 2018-02-27
$12.47M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31-$4.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$3.51M
derived: sum of 2 quarters · filed 2018-02-27
$7.94M
derived: sum of 3 quarters · filed 2018-02-27
$10.49M
10-K · filed 2018-02-27
2015-09-30$7.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$12.35M
derived: sum of 2 quarters · filed 2016-11-03
$14.90M
10-Q · filed 2016-11-03
$18.26M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$4.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$6.98M
10-Q · filed 2016-08-04
$10.33M
derived: sum of 3 quarters · filed 2017-03-01
$13.01M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31$2.55M
10-Q · filed 2016-05-05
$5.90M
derived: sum of 2 quarters · filed 2017-03-01
$8.58M
derived: sum of 3 quarters · filed 2017-03-01
$14.46M
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31$3.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
$6.03M
derived: sum of 2 quarters · filed 2017-03-01
$11.92M
derived: sum of 3 quarters · filed 2017-03-01
$8.81M
10-K · filed 2017-03-01
2014-09-30$2.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
$8.56M
derived: sum of 2 quarters · filed 2015-11-04
$5.46M
10-Q · filed 2015-11-04
-$58.00K
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30$5.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$2.78M
10-Q · filed 2015-08-06
-$2.73M
derived: sum of 3 quarters · filed 2016-02-25
-$7.76M
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31-$3.10M
10-Q · filed 2015-05-08
-$8.62M
derived: sum of 2 quarters · filed 2016-02-25
-$13.65M
derived: sum of 3 quarters · filed 2016-02-25
-$22.46M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31-$5.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
-$10.54M
derived: sum of 2 quarters · filed 2016-02-25
-$19.36M
derived: sum of 3 quarters · filed 2016-02-25
-$7.23M
10-K · filed 2016-02-25
2013-09-30-$5.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
-$13.84M
derived: sum of 2 quarters · filed 2014-11-06
-$1.71M
10-Q · filed 2014-11-06
-$9.11M
derived: sum of 4 quarters · filed 2015-03-03
2013-06-30-$8.81M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
$3.31M
10-Q · filed 2014-08-07
-$4.09M
derived: sum of 3 quarters · filed 2015-03-03
$14.48M
derived: sum of 4 quarters · filed 2015-03-03
2013-03-31$12.13M
10-Q · filed 2014-05-09
$14.99M
10-Q · filed 2013-05-09
$4.73M
derived: sum of 2 quarters · filed 2015-03-03
$23.30M
derived: sum of 3 quarters · filed 2015-03-03
$36.67M
derived: sum of 4 quarters · filed 2015-03-03
2012-12-31-$7.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03
$11.17M
derived: sum of 2 quarters · filed 2015-03-03
$24.54M
derived: sum of 3 quarters · filed 2015-03-03
$25.68M
10-K · filed 2015-03-03
2012-09-30$18.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
$31.94M
derived: sum of 2 quarters · filed 2013-11-07
$33.08M
10-Q · filed 2013-11-07
$37.89M
derived: sum of 4 quarters · filed 2014-02-27
2012-06-30$13.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
$14.51M
10-Q · filed 2013-08-08
$19.32M
derived: sum of 3 quarters · filed 2014-02-27
$22.56M
derived: sum of 4 quarters · filed 2014-02-27
2012-03-31$1.14M
10-Q · filed 2013-05-09
$5.96M
derived: sum of 2 quarters · filed 2014-02-27
$9.19M
derived: sum of 3 quarters · filed 2014-02-27
$10.11M
derived: sum of 4 quarters · filed 2014-02-27
2011-12-31$4.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27
$8.05M
derived: sum of 2 quarters · filed 2014-02-27
$8.97M
derived: sum of 3 quarters · filed 2014-02-27
$5.75M
10-K · filed 2014-02-27
2011-09-30$3.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
$4.15M
derived: sum of 2 quarters · filed 2012-11-08
$932.00K
10-Q · filed 2012-11-08
$2.00M
derived: sum of 4 quarters · filed 2013-02-28
2011-06-30$914.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08
-$2.30M
10-Q · filed 2012-08-08
-$1.23M
derived: sum of 3 quarters · filed 2013-02-28
-$646.00K
derived: sum of 4 quarters · filed 2013-02-28
2011-03-31-$3.22M
10-Q · filed 2012-05-08
-$2.15M
derived: sum of 2 quarters · filed 2013-02-28
-$1.56M
derived: sum of 3 quarters · filed 2013-02-28
2010-12-31$1.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$1.66M
derived: sum of 2 quarters · filed 2013-02-28
$1.48M
10-K · filed 2013-02-28
2010-09-30$585.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
$404.00K
10-Q · filed 2011-11-08
2010-06-30-$181.00K
10-Q · filed 2011-08-09
2009-12-31$897.00K
10-K · filed 2012-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Processa Pharmaceuticals, Inc. (PCSA)United States$0.005B
Dermata Therapeutics, Inc. (DRMA)United States$0.005B-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)United States$0.005B
Xenetic Biosciences, Inc. (XBIO)United States$0.006B
ProPhase Labs, Inc. (PRPH)United States$0.006B-0.06
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Pulmatrix, Inc. (PULM)United States$0.006B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
Ernexa Therapeutics Inc. (ERNA)United States$0.006B